Elanco_CF_Parvo_eblast

#212C5D #dde0e8 {{custommediaemailsadvanced::eyebrow_copy}} #000000 #ffffff {{custommediaemailsadvanced::is_partner_podcast}} Or listen on your favorite{nbs}platform: {{custommediaemailsadvanced::partner_podcast_spotify_url}} {{custommediaemailsadvanced::partner_podcast_apple_url}} {{custommediaemailsadvanced::partner_podcast_google_url}} /uploads/elanco_parvo_c_f_artboard_89_2_x-95631b09229db8eac136de525ed85d44.jpg {{custommediaemailsadvanced::logo_self_hosted}} 118 {{custommediaemailsadvanced::logo_height}} 20px 40px 20px {{custommediaemailsadvanced::logo_alt_text}} {{custommediaemailsadvanced::logo_url}} {{custommediaemailsadvanced::no_border_under_logo}} {{custommediaemailsadvanced::apply_logo_over_background_image}} true /uploads/elanco_parvo_c_f_eblast_header_2_x-8b5f7757544eea158d7f6d21e3871ad8.jpg {{custommediaemailsadvanced::desktop_header_image_alt}} {{custommediaemailsadvanced::desktop_header_image_alt_1x}} true true {{custommediaemailsadvanced::mobile_header_image}} {{custommediaemailsadvanced::mobile_header_image_alt}} {{custommediaemailsadvanced::add_left_right_padding_to_header_image}} {{custommediaemailsadvanced::add_bottom_padding_to_header_image}} {{custommediaemailsadvanced::add_top_padding_to_header_image}} {{custommediaemailsadvanced::header_image_padding_background_color}} {{custommediaemailsadvanced::scale_mobile_header_image}} {{custommediaemailsadvanced::background_height}} #000000 {{custommediaemailsadvanced::headline_image}} {{custommediaemailsadvanced::headline_image_self_hosted}} {{custommediaemailsadvanced::headline_url}} 480 379 {{custommediaemailsadvanced::headline_image_custom_css}} {{custommediaemailsadvanced::place_headline_image_above_header_image}} {{custommediaemailsadvanced::place_headline_image_below_header_image}} {{custommediaemailsadvanced::spacer_image}} {{custommediaemailsadvanced::spacer_image_self_hosted}} 600 {{custommediaemailsadvanced::spacer_image_height}} {{custommediaemailsadvanced::spacer_image_scale_desktop_padding_bottom}} {{custommediaemailsadvanced::spacer_image_scale_mobile_padding_bottom}} {{custommediaemailsadvanced::subhead_copy}} {{custommediaemailsadvanced::large_subhead_copy}} {{custommediaemailsadvanced::subhead_td_custom_css}} {{custommediaemailsadvanced::subhead_span_custom_css}} {{custommediaemailsadvanced::horizontal_rule_under_subhead}} {{custommediaemailsadvanced::intro_copy}} {{custommediaemailsadvanced::intro_centered}} {{custommediaemailsadvanced::intro_copy_td_custom_css}} {{custommediaemailsadvanced::intro_copy_span_custom_css}} {{custommediaemailsadvanced::horizontal_rule_under_intro}}

For decades, veterinarians have managed canine parvovirus patients with nothing more than aggressive supportive care. For the first time since its emergence in the 1970s, a targeted treatment is available. With the introduction of the conditionally approved Canine Parvovirus Monoclonal Antibody therapy, targeted treatment can now not only change patient outcomes but also have broader impacts on the veterinary and shelter community. In this roundtable discussion, see what 6 key opinion leaders had to say about the impacts of this innovative treatment.

{{custommediaemailsadvanced::custom_body_text_color}} {{custommediaemailsadvanced::custom_body_background_color}} padding-bottom: 60px; {{custommediaemailsadvanced::body_span_custom_css}} {{custommediaemailsadvanced::custom_body_horizontal_rule_color}} {{custommediaemailsadvanced::ordered_list_bullet_1}} 1 {{custommediaemailsadvanced::custom_icon_1}} {{custommediaemailsadvanced::custom_icon_1_self_hosted}} {{custommediaemailsadvanced::custom_icon_1_width}} {{custommediaemailsadvanced::ordered_list_bullet_2}} 2 {{custommediaemailsadvanced::custom_icon_2}} {{custommediaemailsadvanced::custom_icon_2_self_hosted}} {{custommediaemailsadvanced::custom_icon_2_width}} {{custommediaemailsadvanced::ordered_list_bullet_3}} 3 {{custommediaemailsadvanced::custom_icon_3}} {{custommediaemailsadvanced::custom_icon_3_self_hosted}} {{custommediaemailsadvanced::custom_icon_3_width}} {{custommediaemailsadvanced::ordered_list_bullet_4}} 4 {{custommediaemailsadvanced::custom_icon_4}} {{custommediaemailsadvanced::custom_icon_4_self_hosted}} {{custommediaemailsadvanced::custom_icon_4_width}} {{custommediaemailsadvanced::ordered_list_bullet_5}} 5 {{custommediaemailsadvanced::custom_icon_5}} {{custommediaemailsadvanced::custom_icon_5_self_hosted}} {{custommediaemailsadvanced::custom_icon_5_width}} #000000 {{custommediaemailsadvanced::center_icons_in_mobile}} {{custommediaemailsadvanced::ordered_list_bullet_td_custom_css}} {{custommediaemailsadvanced::ordered_list_bullet_span_custom_css}} {{custommediaemailsadvanced::body_2_copy}} {{custommediaemailsadvanced::body_2_td_custom_css}} {{custommediaemailsadvanced::body_2_span_custom_css}} {{custommediaemailsadvanced::closing_emphasis_copy}} {{custommediaemailsadvanced::closing_emphasis_link_text}} {{custommediaemailsadvanced::closing_emphasis_link_url}} {{custommediaemailsadvanced::closing_emphasis_link_color}} {{custommediaemailsadvanced::closing_emphasis_td_custom_css}} {{custommediaemailsadvanced::closing_emphasis_span_custom_css}} background: #212c5d What do the experts think? {{custommediaemailsadvanced::cta_line_1_custom_text_color}} true {{custommediaemailsadvanced::cta_line_2}} {{custommediaemailsadvanced::cta_line_2_custom_text_color}} {{custommediaemailsadvanced::cta_line_2_link}} Read the Conversation Now #dde0e8 #212c5d {{custommediaemailsadvanced::button_url}} {{custommediaemailsadvanced::footnote}} {{custommediaemailsadvanced::large_footnote_copy}} {{custommediaemailsadvanced::footnote_td_custom_css}} {{custommediaemailsadvanced::footnote_span_custom_css}} {{custommediaemailsadvanced::pre_footer_copy}} {{custommediaemailsadvanced::pre_footer_center}}

Entering a New Age in the Treatment of Canine Parvovirus

Entering a New Age in the Treatment of Canine Parvovirus